0001610618-22-000015.txt : 20220323
0001610618-22-000015.hdr.sgml : 20220323
20220323181111
ACCESSION NUMBER: 0001610618-22-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220321
FILED AS OF DATE: 20220323
DATE AS OF CHANGE: 20220323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Brady
CENTRAL INDEX KEY: 0001751478
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36912
FILM NUMBER: 22764134
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cidara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001610618
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461537286
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-752-6170
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
STREET 2: SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: K2 THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20140611
4
1
wf-form4_164807345770354.xml
FORM 4
X0306
4
2022-03-21
0
0001610618
Cidara Therapeutics, Inc.
CDTX
0001751478
Johnson Brady
6310 NANCY RIDGE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
Vice President, Finance
Common Stock
2022-03-21
4
S
0
654
0.81
D
49366
D
The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
/s/ Brady Johnson
2022-03-23